

1,402,102 filings since 2004 · latest accepted Nov 4, 2026, 9:38 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Aug 12, 2026 accepted 10:59 AM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Jun 25, 2026 accepted 8:30 PM ET | PLXProtalix BioTherapeutics, Inc. | 5.07Shareholder vote | Document |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
May 21, 2026 accepted 11:03 AM ET | PLXProtalix BioTherapeutics, Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
May 13, 2026 accepted 10:57 AM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Mar 18, 2026 accepted 10:56 AM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Mar 9, 2026 accepted 11:51 AM ET | PLXProtalix BioTherapeutics, Inc. | 8.01Other events | DocumentSEC ↗ |
Feb 11, 2026 accepted 10:10 PM ET | PLXProtalix BioTherapeutics, Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
Jan 30, 2026 accepted 3:09 PM ET | PLXProtalix BioTherapeutics, Inc. | 8.01Other events | DocumentSEC ↗ |
Jan 5, 2026 accepted 11:56 AM ET | PLXProtalix BioTherapeutics, Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
Nov 13, 2025 accepted 11:54 AM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Nov 3, 2025 accepted 9:44 PM ET | PLXProtalix BioTherapeutics, Inc. | 8.01Other events | DocumentSEC ↗ |
Oct 17, 2025 accepted 12:08 PM ET | PLXProtalix BioTherapeutics, Inc. | 7.01Reg FD disclosure8.01Other events | DocumentSEC ↗ |
Aug 22, 2025 accepted 8:39 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Aug 14, 2025 accepted 10:58 AM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Aug 1, 2025 accepted 8:30 PM ET | PLXProtalix BioTherapeutics, Inc. | 8.01Other events | DocumentSEC ↗ |
Jul 21, 2025 accepted 1:27 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement5.02Officer / director change | DocumentSEC ↗ |
Jun 26, 2025 accepted 8:30 PM ET | PLXProtalix BioTherapeutics, Inc. | 5.07Shareholder vote | DocumentSEC ↗ |
May 9, 2025 accepted 10:57 AM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Apr 23, 2025 accepted 8:30 PM ET | PLXProtalix BioTherapeutics, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Mar 17, 2025 accepted 9:19 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Mar 17, 2025 accepted 10:55 AM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Dec 31, 2024 accepted 9:30 PM ET | PLXProtalix BioTherapeutics, Inc. | 3.03Holder rights modified5.03Bylaws / fiscal year | DocumentSEC ↗ |
Dec 23, 2024 accepted 12:01 PM ET | PLXProtalix BioTherapeutics, Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
Nov 14, 2024 accepted 11:57 AM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Oct 25, 2024 accepted 12:27 PM ET | PLXProtalix BioTherapeutics, Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
Aug 14, 2024 accepted 10:56 AM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Jun 28, 2024 accepted 9:32 PM ET | PLXProtalix BioTherapeutics, Inc. | 5.07Shareholder vote | DocumentSEC ↗ |
May 10, 2024 accepted 10:59 AM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Mar 14, 2024 accepted 10:57 AM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Dec 26, 2023 accepted 11:56 AM ET | PLXProtalix BioTherapeutics, Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
Nov 6, 2023 accepted 12:22 PM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Sep 12, 2023 accepted 10:58 AM ET | PLXProtalix BioTherapeutics, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Aug 7, 2023 accepted 10:59 AM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Jul 13, 2023 accepted 8:41 PM ET | PLXProtalix BioTherapeutics, Inc. | 5.07Shareholder vote | DocumentSEC ↗ |
Jun 29, 2023 accepted 11:24 AM ET | PLXProtalix BioTherapeutics, Inc. | 5.07Shareholder vote | DocumentSEC ↗ |
May 30, 2023 accepted 11:23 AM ET | PLXProtalix BioTherapeutics, Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
May 18, 2023 accepted 10:57 AM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release8.01Other events | DocumentSEC ↗ |
May 10, 2023 accepted 10:25 AM ET | PLXProtalix BioTherapeutics, Inc. | 8.01Other events | DocumentSEC ↗ |
May 5, 2023 accepted 10:56 AM ET | PLXProtalix BioTherapeutics, Inc. | 8.01Other events | DocumentSEC ↗ |
May 4, 2023 accepted 11:37 AM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Feb 27, 2023 accepted 11:48 AM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Feb 27, 2023 accepted 11:36 AM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Feb 24, 2023 accepted 2:26 PM ET | PLXProtalix BioTherapeutics, Inc. | 8.01Other events | DocumentSEC ↗ |
Jan 3, 2023 accepted 11:57 AM ET | PLXProtalix BioTherapeutics, Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
Dec 27, 2022 accepted 9:30 PM ET | PLXProtalix BioTherapeutics, Inc. | 8.01Other events | DocumentSEC ↗ |
Dec 21, 2022 accepted 9:36 PM ET | PLXProtalix BioTherapeutics, Inc. | 8.01Other events | DocumentSEC ↗ |
Nov 14, 2022 accepted 12:03 PM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release8.01Other events | DocumentSEC ↗ |
Sep 1, 2022 accepted 8:31 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Aug 15, 2022 accepted 11:04 AM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Jun 30, 2022 accepted 9:10 PM ET | PLXProtalix BioTherapeutics, Inc. | 5.02Officer / director change5.07Shareholder vote8.01Other events | DocumentSEC ↗ |